• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ProPhase Labs Inc

+ Add to Watchlist

QGY:GR

1.076 EUR 0.001 0.09%

As of 02:08:44 ET on 10/23/2014.

Snapshot for ProPhase Labs Inc (QGY)

Open: 1.076 Day's Range: 1.076 - 1.076 Volume: 0
Previous Close: 1.077 52wk Range: 0.937 - 1.588 1-Yr Rtn: -14.74%

Stock Chart for QGY

No chart data available.
  • QGY:GR 1.076
  • 1M
  • 1Y
1.077
Interactive QGY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QGY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 20.77
Shares Outstanding (M) 19.30
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QGY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QGY

ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The Company's products reduce the duration and severity of common cold symptoms. ProPhase also manufactures nutrition and weight management products.

Ted KarkusChairman/CEORobert V Cuddihy JrExec VP/CFO/COO
More Company Profile & Key Executives for QGY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil